About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Path Breaking Method to Analyze Prostrate Cancer Developed

by Rathi Manohar on June 27, 2010 at 12:33 PM
Font : A-A+

Path Breaking Method to Analyze Prostrate Cancer Developed

The most comprehensive genomic analysis of prostate cancer has been developed by scientists who hope this will help to develop patient subgroups and in making individual treatment decisions.

"One of the holy grails of prostate cancer is to identify which tumors need to be aggressively treated and which don't. Ultimately, what we have learned could lead to the creation of a genetic-based test to determine which prostate cancers might become more virulent and require aggressive treatment and which tumors may not," said senior study author Charles Sawyers, from Memorial Sloan-Kettering Cancer Center (MSKCC).

Advertisement

The difference between aggressive treatment and a "wait and watch" approach has obvious quality-of-life implications for prostate cancer patients.

The MSKCC team used an integrated, comprehensive approach to analyze 218 primary and metastatic samples and 12 cell lines. All samples were procured from patients treated by radical prostatectomy at MSKCC.
Advertisement

The analysis revealed a much higher frequency of alterations in the androgen receptor pathway than previously suspected. Also, the pattern of DNA copy number alterations identified defined subsets of low-and high-risk disease beyond what is revealed by Gleason score.

The study has been published early online on June 24 in the journal Cancer Cell.

Source: ANI
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Cancer News

Why Is Time of Day Important in Cancer Diagnosis and Treatment?
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
How Do Neutrophils Impact Pancreatic Cancer Treatment Resistance?
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
Lung Cancer: The Survival Advantage of Lobectomy Over Wedge Resection
The survival rates between lobectomy and wedge resection surgical procedures were found to be the same among lung cancer patients.
Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Path Breaking Method to Analyze Prostrate Cancer Developed Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests